| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
1 Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland and 2 Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland
Requests for reprints: Yves Pommier, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Building 37, Room 5068, 37 Convent Drive, Bethesda, MD 20892-4255. Phone: 301-496-5944; Fax: 301-401-0752; pommier{at}nih.gov.
Aminoflavone (5-amino-2,3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one) (NSC 686288) is a candidate for possible advancement to phase I clinical trial. Aminoflavone has a unique activity profile in the NCI 60 cell lines (COMPARE analysis; http://www.dtp.nci.nih.gov/docs/dtp_search.html), and exhibits potent cellular and animal antitumor activity. To elucidate the mechanism of action of aminoflavone, we studied DNA damage in MCF-7 cells. Aminoflavone induced DNA-protein cross-links (DPC) and DNA single-strand breaks (SSB). Aminoflavone induced high levels of DPC and much lower level of SSB than camptothecin, which induces equal levels of DPC and SSB due to the trapping topoisomerase I-DNA complexes. Accordingly, neither topoisomerase I nor topoisomerase II were detectable in the aminoflavone-induced DPC. Aminoflavone also induced dose- and time-dependent histone H2AX phosphorylation (
-H2AX).
-H2AX foci occurred with DPC formation, and like DPC, persisted after aminoflavone removal. Aphidicolin prevented
-H2AX formation, suggesting that
-H2AX foci correspond to replication-associated DNA double-strand breaks. Accordingly, no
-H2AX foci were found in proliferating cell nuclear antigennegative or in mitotic cells. Bromodeoxyuridine incorporation and fluorescence-activated cell sorting analyses showed DNA synthesis inhibition uniformly throughout the S phase after exposure to aminoflavone. Aminoflavone also induced RPA2 and p53 phosphorylation, and induced p21Waf1/Cip1 and MDM2, demonstrating S-phase checkpoint activation. These studies suggest that aminoflavone produces replication-dependent DNA lesions and S-phase checkpoint activation following DPC formation.
-H2AX may be a useful clinical marker for monitoring the efficacy of aminoflavone in tumor therapies.
This article has been cited by other articles:
![]() |
J. Guirouilh-Barbat, C. Redon, and Y. Pommier Transcription-coupled DNA Double-Strand Breaks Are Mediated via the Nucleotide Excision Repair and the Mre11-Rad50-Nbs1 Complex Mol. Biol. Cell, September 1, 2008; 19(9): 3969 - 3981. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai, Z. Chen, K. E. Bailey, D. A. Scollard, R. M. Reilly, and K. A. Vallis Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF J. Nucl. Med., August 1, 2008; 49(8): 1353 - 1361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-h. Meng, Z. Meng, Z.-h. Miao, T. D. Veenstra, and Y. Pommier Cytokeratin-RNA Cross-Linking Mediated by the Antitumor Aminoflavone, 5-Amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 674 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pommier DNA Repair Modulators as Anticancer Agents ASCO Educational Book, January 1, 2008; 2008(1): 128 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cheng, K. Shin-ya, R. Wan, S.-c. Tang, T. Miura, H. Tang, R. Khatri, M. Gleichman, X. Ouyang, D. Liu, et al. Telomere Protection Mechanisms Change during Neurogenesis and Neuronal Maturation: Newly Generated Neurons Are Hypersensitive to Telomere and DNA Damage J. Neurosci., April 4, 2007; 27(14): 3722 - 3733. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-h. Meng, U. Shankavaram, C. Chen, K. Agama, H.-q. Fu, F. J. Gonzalez, J. Weinstein, and Y. Pommier Activation of Aminoflavone (NSC 686288) by a Sulfotransferase Is Required for the Antiproliferative Effect of the Drug and for Induction of Histone {gamma}-H2AX Cancer Res., October 1, 2006; 66(19): 9656 - 9664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, L. Meng, X. Ma, K. W. Krausz, Y. Pommier, J. R. Idle, and F. J. Gonzalez Urinary Metabolite Profiling Reveals CYP1A2-Mediated Metabolism of NSC686288 (Aminoflavone) J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1330 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-H. Miao, V. A. Rao, K. Agama, S. Antony, K. W. Kohn, and Y. Pommier 4-Nitroquinoline-1-Oxide Induces the Formation of Cellular Topoisomerase I-DNA Cleavage Complexes. Cancer Res., July 1, 2006; 66(13): 6540 - 6545. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |